Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
June 2012 Volume 3 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June 2012 Volume 3 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro

  • Authors:
    • Nannan Tong
    • Jie Zhang
    • Youran Chen
    • Zhubo Li
    • Yonghuang Luo
    • Hua Zuo
    • Xiaoyan Zhao
  • View Affiliations / Copyright

    Affiliations: College of Pharmaceutical Sciences, Southwest University, Chongqing 400716, P.R. China, Department of Neurology, Chongqing Three Gorges Central Hospital, Chongqing 404000, P.R. China
  • Pages: 1263-1267
    |
    Published online on: March 14, 2012
       https://doi.org/10.3892/ol.2012.644
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The clinical use of doxorubicin (DOX), a potent antineoplastic agent, is limited by its serious side-effects, which include acute and chronic cumulative dose-related cardiotoxicity. Berberine (BER), a botanical alkaloid, has been reported to possess cardioprotective and antitumor effects. The 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-tetrazolium bromide (MTT) assay was used to detect the cell viability of A549, HeLa and HepG2 cells after each cell line was treated with DOX, BER or a combination of DOX and BER for 24 h. Apoptosis was evaluated by acridine orange staining. The results showed that BER and DOX exhibited dose-dependent inhibitory effects on A549 and HeLa cells which were likely mediated by inducing apoptosis. The same result was found in the combination group. Isobologram illustration and combination index (CI) analyses revealed that the combination of DOX and BER generates synergistic effects in A549 (CI=0.61) and HeLa (CI=0.73) cells. These findings indicate that BER sensitizes cells to the anticancer effects of DOX.
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Henderson IC and Frei TE III: Adriamycin and the heart. N Engl J Med. 300:310–312. 1979. View Article : Google Scholar

2 

Christiansen S and Autschbach R: Doxorubicin in experimental and clinical heart failure. Eur J Cardiothorac Surg. 30:611–616. 2006. View Article : Google Scholar : PubMed/NCBI

3 

Binaschi M, Capranico G, Dal Bo L and Zunino F: Relationship between lethal effects and topoisomerase II mediated double-strand DNA breaks produced by anthracyclines with different sequence specificity. Mol Pharmacol. 51:1053–1059. 1997.

4 

Hennig UG, Rudd NL and Hoar DI: Kinetochore immunofluorescence in micronuclei: a rapid method for the in situ detection of aneuploidy and chromosome breakage in human fibroblasts. Mutat Res. 203:405–414. 1988. View Article : Google Scholar : PubMed/NCBI

5 

Boucek RJ Jr, Dodd DA, Atkinson JB, Oquist N and Olson RD: Contractile failure in chronic doxorubicin-induced cardiomyopathy. J Mol Cell Cardiol. 29:2631–2640. 1997. View Article : Google Scholar : PubMed/NCBI

6 

Doroshow JH: Effect of anthracyline antibiotics on oxygen radical formation in rat heart. Cancer Res. 43:460–472. 1983.PubMed/NCBI

7 

Ichihara S, Yamada Y, Kawai Y, Osawa T, Furuhashi K, Duan Z and Ichihara G: Roles of oxidative stress and Akt signaling in doxorubicin cardiotoxicity. Biochem Biophys Res Commun. 359:27–33. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Temma K, Chugun A, Akera T, Hara Y, Sasaki T and Kondo H: Ca2+ overloading causes the negative inotropic effect of doxorubicin in myocytes isolated from guinea-pig hearts. Eur J Pharmacol. 322:235–242. 1997.

9 

Timothy CB and Gregory SK: Berberine: therapeutic potential of an alkaloid found in several medicinal plants. Altern Med Rev. 2:94–102. 1997.

10 

Takase H, Yamamoto K, Ito K and Yumioka E: Pharmacological studies on antidiarrheal effects of berberine and geranii herb. Nihon Yakurigaku Zasshi. 102:101–112. 1993.(In Japanese).

11 

Iwazaki RS, Endo EH, Ueda-Nakamura T, Nakamura CV, Garcia LB and Filho BP: In vitro antifungal activity of the berberine and its synergism with fluconazole. Antonie Van Leeuwenhoek. 97:201–205. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Zhang H, Wei J, Xue R, et al: Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism. 59:285–292. 2010. View Article : Google Scholar

13 

Zhao X, Zhang JJ, Wang X, Bu XY, Lou YQ and Zhang GL: Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital- treated rats. Biomed Pharmacother. 62:567–572. 2008. View Article : Google Scholar

14 

Janbaz KH and Gilani AH: Studies on preventive and curative effects of berberine on chemical-induced hepatotoxicity in rodents. Fitoterapia. 71:25–33. 2000. View Article : Google Scholar : PubMed/NCBI

15 

Zhou JY, Zhou SW, Tang JL, Xu Y and Ying Y: Effect of berberine on Cdk9 and cyclin T1 expressions in myocardium of diabetic rats. J Med Coll PLA. 23:45–51. 2008. View Article : Google Scholar

16 

Zeng XH, Zeng XJ and Li YY: Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 92:173–176. 2003. View Article : Google Scholar : PubMed/NCBI

17 

Salehi S and Filtz TM: Berberine possesses muscarinic agonist-like properties in cultured rodent cardiomyocytes. Pharmacol Res. 63:335–340. 2011. View Article : Google Scholar : PubMed/NCBI

18 

Patil JB, Kim J and Jayaprakasha GK: Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol. 645:70–78. 2010. View Article : Google Scholar : PubMed/NCBI

19 

Kuo CL, Chou CC and Yung BY: Berberine complexes with DNA in the berberine-induced apoptosis in human leukemic HL-60 cells. Cancer Lett. 93:193–200. 1995. View Article : Google Scholar : PubMed/NCBI

20 

Tsang CM, Lau EP, Di K, et al: Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells. Int J Mol Med. 24:131–138. 2009.PubMed/NCBI

21 

Kim JB, Yu JH, Ko E, et al: The alkaloid berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest. Phytomedicine. 17:436–440. 2010. View Article : Google Scholar : PubMed/NCBI

22 

Kheir MM, Wang YG, Hua L, Hu J, Li LL, Lei F and Du L: Acute toxicity of berberine and its correlation with the blood concentration in mice. Food Chem Toxicol. 48:1105–1110. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Chou TC and Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 22:27–55. 1984. View Article : Google Scholar : PubMed/NCBI

24 

Tallarida RJ: Drug synergism: Its detection and applications. J Pharmacol Exp Ther. 298:865–872. 2001.PubMed/NCBI

25 

Yoshida M, Shiojima I, Ikeda H and Komuro l: Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. J Mol Cell Cardiol. 47:698–705. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Peng PL, Hsieh YS, Wang CJ, Hsu JL and Chou FP: Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicol Appl Pharmacol. 214:8–15. 2006. View Article : Google Scholar : PubMed/NCBI

27 

Yan K, Zhang C, Feng J, et al: Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells. Eur J Pharmacol. 661:1–7. 2011. View Article : Google Scholar : PubMed/NCBI

28 

Meeran SM, Katiyar S and Katiyar SK: Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol. 229:33–43. 2008. View Article : Google Scholar : PubMed/NCBI

29 

Bliss CI: The toxicity of poisons applied jointly. Ann Appl Biol. 26:585–615. 1939. View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tong N, Zhang J, Chen Y, Li Z, Luo Y, Zuo H and Zhao X: Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncol Lett 3: 1263-1267, 2012.
APA
Tong, N., Zhang, J., Chen, Y., Li, Z., Luo, Y., Zuo, H., & Zhao, X. (2012). Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncology Letters, 3, 1263-1267. https://doi.org/10.3892/ol.2012.644
MLA
Tong, N., Zhang, J., Chen, Y., Li, Z., Luo, Y., Zuo, H., Zhao, X."Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro". Oncology Letters 3.6 (2012): 1263-1267.
Chicago
Tong, N., Zhang, J., Chen, Y., Li, Z., Luo, Y., Zuo, H., Zhao, X."Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro". Oncology Letters 3, no. 6 (2012): 1263-1267. https://doi.org/10.3892/ol.2012.644
Copy and paste a formatted citation
x
Spandidos Publications style
Tong N, Zhang J, Chen Y, Li Z, Luo Y, Zuo H and Zhao X: Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncol Lett 3: 1263-1267, 2012.
APA
Tong, N., Zhang, J., Chen, Y., Li, Z., Luo, Y., Zuo, H., & Zhao, X. (2012). Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro. Oncology Letters, 3, 1263-1267. https://doi.org/10.3892/ol.2012.644
MLA
Tong, N., Zhang, J., Chen, Y., Li, Z., Luo, Y., Zuo, H., Zhao, X."Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro". Oncology Letters 3.6 (2012): 1263-1267.
Chicago
Tong, N., Zhang, J., Chen, Y., Li, Z., Luo, Y., Zuo, H., Zhao, X."Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin in vitro". Oncology Letters 3, no. 6 (2012): 1263-1267. https://doi.org/10.3892/ol.2012.644
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team